3.19.1 html 166 234 1 true 59 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.beyondspringpharma.com/20181231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.beyondspringpharma.com/20181231/role/statement-consolidated-balance-sheets- Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.beyondspringpharma.com/20181231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://www.beyondspringpharma.com/20181231/role/statement-consolidated-statements-of-comprehensive-loss- Consolidated Statements of Comprehensive Loss Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Comprehensive Loss (Parentheticals) Sheet http://www.beyondspringpharma.com/20181231/role/statement-consolidated-statements-of-comprehensive-loss-parentheticals Consolidated Statements of Comprehensive Loss (Parentheticals) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Shareholders' Equity (Deficit) Sheet http://www.beyondspringpharma.com/20181231/role/statement-consolidated-statements-of-shareholders-equity-deficit Consolidated Statements of Shareholders' Equity (Deficit) Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.beyondspringpharma.com/20181231/role/statement-consolidated-statements-of-cash-flows- Consolidated Statements of Cash Flows Statements 7 false false R8.htm 007 - Disclosure - Note 1 - Nature of the Business Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-1-nature-of-the-business- Note 1 - Nature of the Business Notes 8 false false R9.htm 008 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Note 3 - Property and Equipment, Net Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-3-property-and-equipment-net Note 3 - Property and Equipment, Net Notes 10 false false R11.htm 010 - Disclosure - Note 4 - Related Party Transactions Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-4-related-party-transactions Note 4 - Related Party Transactions Notes 11 false false R12.htm 011 - Disclosure - Note 5 - Income Taxes Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-5-income-taxes Note 5 - Income Taxes Notes 12 false false R13.htm 012 - Disclosure - Note 6 - Net Loss Per Share Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-6-net-loss-per-share Note 6 - Net Loss Per Share Notes 13 false false R14.htm 013 - Disclosure - Note 7 - Share Based Compensation Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-7-share-based-compensation Note 7 - Share Based Compensation Notes 14 false false R15.htm 014 - Disclosure - Note 8 - Employee Defined Contribution Plan Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-8-employee-defined-contribution-plan Note 8 - Employee Defined Contribution Plan Notes 15 false false R16.htm 015 - Disclosure - Note 9 - Restricted Net Assets Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-9-restricted-net-assets Note 9 - Restricted Net Assets Notes 16 false false R17.htm 016 - Disclosure - Note 10 - Commitments and Contingencies Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-10-commitments-and-contingencies Note 10 - Commitments and Contingencies Notes 17 false false R18.htm 017 - Disclosure - Note 11 - Subsequent Events Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-11-subsequent-events- Note 11 - Subsequent Events Notes 18 false false R19.htm 018 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.beyondspringpharma.com/20181231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.beyondspringpharma.com/20181231/role/statement-note-2-summary-of-significant-accounting-policies 19 false false R20.htm 019 - Disclosure - Note 1 - Nature of the Business (Tables) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-1-nature-of-the-business-tables Note 1 - Nature of the Business (Tables) Tables http://www.beyondspringpharma.com/20181231/role/statement-note-1-nature-of-the-business- 20 false false R21.htm 020 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://www.beyondspringpharma.com/20181231/role/statement-note-2-summary-of-significant-accounting-policies 21 false false R22.htm 021 - Disclosure - Note 3 - Property and Equipment, Net (Tables) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-3-property-and-equipment-net-tables Note 3 - Property and Equipment, Net (Tables) Tables http://www.beyondspringpharma.com/20181231/role/statement-note-3-property-and-equipment-net 22 false false R23.htm 022 - Disclosure - Note 5 - Income Taxes (Tables) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-5-income-taxes-tables Note 5 - Income Taxes (Tables) Tables http://www.beyondspringpharma.com/20181231/role/statement-note-5-income-taxes 23 false false R24.htm 023 - Disclosure - Note 6 - Net Loss Per Share (Tables) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-6-net-loss-per-share-tables Note 6 - Net Loss Per Share (Tables) Tables http://www.beyondspringpharma.com/20181231/role/statement-note-6-net-loss-per-share 24 false false R25.htm 024 - Disclosure - Note 7 - Share Based Compensation (Tables) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-7-share-based-compensation-tables Note 7 - Share Based Compensation (Tables) Tables http://www.beyondspringpharma.com/20181231/role/statement-note-7-share-based-compensation 25 false false R26.htm 025 - Disclosure - Note 10 - Commitments and Contingencies (Tables) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-10-commitments-and-contingencies-tables Note 10 - Commitments and Contingencies (Tables) Tables http://www.beyondspringpharma.com/20181231/role/statement-note-10-commitments-and-contingencies 26 false false R27.htm 026 - Disclosure - Note 1 - Nature of the Business (Details Textual) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-1-nature-of-the-business-details-textual Note 1 - Nature of the Business (Details Textual) Details http://www.beyondspringpharma.com/20181231/role/statement-note-1-nature-of-the-business-tables 27 false false R28.htm 027 - Disclosure - Note 1 - Nature of the Business - Schedule of Subsidiaries (Details) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-1-nature-of-the-business-schedule-of-subsidiaries-details Note 1 - Nature of the Business - Schedule of Subsidiaries (Details) Details 28 false false R29.htm 028 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://www.beyondspringpharma.com/20181231/role/statement-note-2-summary-of-significant-accounting-policies-tables 29 false false R30.htm 029 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Useful Life of Property, Plant, and Equipment (Details) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-2-summary-of-significant-accounting-policies-useful-life-of-property-plant-and-equipment-details Note 2 - Summary of Significant Accounting Policies - Useful Life of Property, Plant, and Equipment (Details) Details 30 false false R31.htm 030 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Property and Equipment by Geographical Location (Details) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-2-summary-of-significant-accounting-policies-property-and-equipment-by-geographical-location-details Note 2 - Summary of Significant Accounting Policies - Property and Equipment by Geographical Location (Details) Details 31 false false R32.htm 031 - Disclosure - Note 3 - Property and Equipment, Net (Details Textual) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-3-property-and-equipment-net-details-textual Note 3 - Property and Equipment, Net (Details Textual) Details http://www.beyondspringpharma.com/20181231/role/statement-note-3-property-and-equipment-net-tables 32 false false R33.htm 032 - Disclosure - Note 3 - Property and Equipment, Net - Schedule of Property and Equipment (Details) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-3-property-and-equipment-net-schedule-of-property-and-equipment-details Note 3 - Property and Equipment, Net - Schedule of Property and Equipment (Details) Details 33 false false R34.htm 033 - Disclosure - Note 4 - Related Party Transactions (Details Textual) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-4-related-party-transactions-details-textual Note 4 - Related Party Transactions (Details Textual) Details http://www.beyondspringpharma.com/20181231/role/statement-note-4-related-party-transactions 34 false false R35.htm 034 - Disclosure - Note 5 - Income Taxes (Details Textual) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-5-income-taxes-details-textual Note 5 - Income Taxes (Details Textual) Details http://www.beyondspringpharma.com/20181231/role/statement-note-5-income-taxes-tables 35 false false R36.htm 035 - Disclosure - Note 5 - Income Taxes - Components of Losses Before Income Taxes (Details) Sheet http://www.beyondspringpharma.com/20181231/role/statement--note-5-income-taxes-components-of-losses-before-income-taxes-details Note 5 - Income Taxes - Components of Losses Before Income Taxes (Details) Details 36 false false R37.htm 036 - Disclosure - Note 5 - Income Taxes - Reconciliation of Income Tax Expenses (Details) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-5-income-taxes-reconciliation-of-income-tax-expenses-details Note 5 - Income Taxes - Reconciliation of Income Tax Expenses (Details) Details 37 false false R38.htm 037 - Disclosure - Note 5 - Income Taxes - Deferred Tax Assets (Details) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-5-income-taxes-deferred-tax-assets-details Note 5 - Income Taxes - Deferred Tax Assets (Details) Details 38 false false R39.htm 038 - Disclosure - Note 6 - Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-6-net-loss-per-share-basic-and-diluted-net-loss-per-share-details Note 6 - Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details) Details 39 false false R40.htm 039 - Disclosure - Note 7 - Share Based Compensation (Details Textual) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-7-share-based-compensation-details-textual Note 7 - Share Based Compensation (Details Textual) Details http://www.beyondspringpharma.com/20181231/role/statement-note-7-share-based-compensation-tables 40 false false R41.htm 040 - Disclosure - Note 7 - Share-based Compensation - Restricted Share Activities (Details) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-7-sharebased-compensation-restricted-share-activities-details Note 7 - Share-based Compensation - Restricted Share Activities (Details) Details 41 false false R42.htm 041 - Disclosure - Note 7 - Share-based Compensation - Options Activities (Details) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-7-sharebased-compensation-options-activities-details Note 7 - Share-based Compensation - Options Activities (Details) Details 42 false false R43.htm 042 - Disclosure - Note 7 - Share-based Compensation - Fair Value Assumptions (Details) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-7-sharebased-compensation-fair-value-assumptions-details Note 7 - Share-based Compensation - Fair Value Assumptions (Details) Details 43 false false R44.htm 043 - Disclosure - Note 7 - Share-based Compensation - Share-based Compensation Expense (Details) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-7-sharebased-compensation-sharebased-compensation-expense-details Note 7 - Share-based Compensation - Share-based Compensation Expense (Details) Details 44 false false R45.htm 044 - Disclosure - Note 8 - Employee Defined Contribution Plan (Details Textual) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-8-employee-defined-contribution-plan-details-textual Note 8 - Employee Defined Contribution Plan (Details Textual) Details http://www.beyondspringpharma.com/20181231/role/statement-note-8-employee-defined-contribution-plan 45 false false R46.htm 045 - Disclosure - Note 9 - Restricted Net Assets (Details Textual) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-9-restricted-net-assets-details-textual Note 9 - Restricted Net Assets (Details Textual) Details http://www.beyondspringpharma.com/20181231/role/statement-note-9-restricted-net-assets 46 false false R47.htm 046 - Disclosure - Note 10 - Commitments and Contingencies (Details Textual) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-10-commitments-and-contingencies-details-textual Note 10 - Commitments and Contingencies (Details Textual) Details http://www.beyondspringpharma.com/20181231/role/statement-note-10-commitments-and-contingencies-tables 47 false false R48.htm 047 - Disclosure - Note 10 - Commitments and Contingencies - Future Minimum Lease Payments Under Operating Lease (Details) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-10-commitments-and-contingencies-future-minimum-lease-payments-under-operating-lease-details Note 10 - Commitments and Contingencies - Future Minimum Lease Payments Under Operating Lease (Details) Details 48 false false R49.htm 048 - Disclosure - Note 11 - Subsequent Events (Details Textual) Sheet http://www.beyondspringpharma.com/20181231/role/statement-note-11-subsequent-events-details-textual Note 11 - Subsequent Events (Details Textual) Details http://www.beyondspringpharma.com/20181231/role/statement-note-11-subsequent-events- 49 false false All Reports Book All Reports bysi-20181231.xml bysi-20181231.xsd bysi-20181231_cal.xml bysi-20181231_def.xml bysi-20181231_lab.xml bysi-20181231_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 true true